About us

The Harris Lab uses a large repertoire of model systems and experimental approaches to understand how DNA mutating enzymes (APOBECs) provide immunity against viral infections, yet in many cases also contribute to tumor evolution through genomic DNA mutagenesis. Another goal of the Harris Lab is to translate these fundamental scientific discoveries into novel therapeutics against viruses and cancer.

Recent News

September 2016
A new paper by PhD. student Gabriel Starrett titled, "The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis," published in Nature Communications reveals a novel source of mutation in cancer. Links for press release: UMN News, Nature Communications

August 2016
The Harris lab welcomes two new members, Drs. Teneale Stewart and Rena Levin-Klein!

July 2016
Ph.D. Student Gabriel Starrett along with our collaborators at the University of Alabama-Birmingham recently published the article "Functional upregulation of the DNA cytosine deaminase APOBEC3B by polyomaviruses" in the Journal of Virology.

See more...